• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫组化分析作为预测患者对癌症治疗反应的指标:前景与挑战。

Immunoprofiling as a predictor of patient's response to cancer therapy-promises and challenges.

机构信息

Martin Luther University Halle-Wittenberg, Institute of Pathology, Halle, Germany; Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, United States.

Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, United States; School of Medicine, Oregon Health & Science University, Portland, OR, United States.

出版信息

Curr Opin Immunol. 2017 Apr;45:60-72. doi: 10.1016/j.coi.2017.01.005. Epub 2017 Feb 20.

DOI:10.1016/j.coi.2017.01.005
PMID:28222333
Abstract

Immune cell infiltration is common to many tumors and has been recognized by pathologists for more than 100 years. The application of digital imaging and objective assessment software allowed a concise determination of the type and quantity of immune cells and their location relative to the tumor and, in the case of colon cancer, characterized overall survival better than AJCC TNM staging. Subsequently, expression of PD-L1, by 50% or more tumor cells, identified NSCLC patients with double the response rate to anti-PD-1. Soon, automated staining methods will improve reproducibility of multiplex staining and allow for CLIA standards so that multiplex staining can be used to make clinical decisions. Ultimately, machine-learning algorithms will help interpret data from tissue images and lead to improved delivery of precision medicine.

摘要

免疫细胞浸润在许多肿瘤中很常见,这一现象已被病理学家认识了 100 多年。数字成像和客观评估软件的应用,可以简洁地确定免疫细胞的类型和数量,以及它们相对于肿瘤的位置,在结肠癌的情况下,其对总生存期的判断优于 AJCC TNM 分期。随后,肿瘤细胞表达 PD-L1 达到 50%或以上,可识别出对 PD-1 抗体的反应率增加一倍的非小细胞肺癌患者。不久,自动化染色方法将提高多重染色的可重复性,并达到 CLIA 标准,从而使多重染色可用于做出临床决策。最终,机器学习算法将有助于解释组织图像数据,并改善精准医疗的实施。

相似文献

1
Immunoprofiling as a predictor of patient's response to cancer therapy-promises and challenges.免疫组化分析作为预测患者对癌症治疗反应的指标:前景与挑战。
Curr Opin Immunol. 2017 Apr;45:60-72. doi: 10.1016/j.coi.2017.01.005. Epub 2017 Feb 20.
2
The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery.非小细胞肺癌的免疫微环境与手术后的预后相关。
Mol Oncol. 2019 May;13(5):1166-1179. doi: 10.1002/1878-0261.12475. Epub 2019 Apr 10.
3
Interferon-related secretome from direct interaction between immune cells and tumor cells is required for upregulation of PD-L1 in tumor cells.肿瘤细胞中PD-L1的上调需要免疫细胞与肿瘤细胞直接相互作用产生的干扰素相关分泌蛋白组。
Protein Cell. 2016 Jul;7(7):538-43. doi: 10.1007/s13238-016-0281-6.
4
PD-L1 and immune escape: insights from melanoma and other lineage-unrelated malignancies.程序性死亡受体-1配体(PD-L1)与免疫逃逸:来自黑色素瘤及其他非谱系相关恶性肿瘤的见解
Hum Pathol. 2017 Aug;66:13-33. doi: 10.1016/j.humpath.2017.06.012. Epub 2017 Jul 8.
5
[Predictive PD-L1 immunohistochemistry for non-small cell lung cancer : Current state of the art and experiences of the first German harmonization study].[非小细胞肺癌的预测性程序性死亡受体 1 免疫组化:当前技术水平及德国首次协调研究经验]
Pathologe. 2016 Nov;37(6):557-567. doi: 10.1007/s00292-016-0189-1.
6
Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses.受乳腺肿瘤影响的B细胞获得LAP/TGF-β和PD-L1表达并抑制抗肿瘤免疫反应。
Int Immunol. 2016 Sep;28(9):423-33. doi: 10.1093/intimm/dxw007. Epub 2016 Feb 19.
7
Monoclonal antibody 14C5 targets integrin alphavbeta5.单克隆抗体14C5靶向整合素αvβ5。
Mol Cancer Ther. 2008 Dec;7(12):3771-9. doi: 10.1158/1535-7163.MCT-08-0600.
8
A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC Study.一项关于度伐鲁单抗(MEDI4736)联合或不联合曲美木单抗用于既往接受过治疗的晚期非小细胞肺癌患者的III期研究:ARCTIC研究的原理与方案设计。
Clin Lung Cancer. 2016 May;17(3):232-236.e1. doi: 10.1016/j.cllc.2016.03.003. Epub 2016 Mar 17.
9
Comparison of mRNA Expression Measured with the CheckPoint Typer® Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung Cancer.在非小细胞肺癌中,使用CheckPoint Typer®检测法测量的mRNA表达与通过免疫组织化学评估的PD-L1蛋白表达的比较。
Anticancer Res. 2017 Dec;37(12):6771-6778. doi: 10.21873/anticanres.12137.
10
PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project.PD-L1 免疫组织化学检测在肺癌中的应用:蓝图 PD-L1 IHC 检测比较项目第一阶段的结果。
J Thorac Oncol. 2017 Feb;12(2):208-222. doi: 10.1016/j.jtho.2016.11.2228. Epub 2016 Nov 29.

引用本文的文献

1
Artificial Intelligence in Point-of-Care Biosensing: Challenges and Opportunities.即时护理生物传感中的人工智能:挑战与机遇
Diagnostics (Basel). 2024 May 25;14(11):1100. doi: 10.3390/diagnostics14111100.
2
A novel CD8+ T cell-related gene signature as a prognostic biomarker in hepatocellular carcinoma.一种新型的 CD8+ T 细胞相关基因特征作为肝细胞癌的预后生物标志物。
Medicine (Baltimore). 2024 Mar 15;103(11):e37496. doi: 10.1097/MD.0000000000037496.
3
Differential Immune Infiltration Profiles in Colitis-Associated Colorectal Cancer versus Sporadic Colorectal Cancer.
结肠炎相关结直肠癌与散发性结直肠癌的差异免疫浸润谱
Cancers (Basel). 2023 Sep 27;15(19):4743. doi: 10.3390/cancers15194743.
4
Clinical Usefulness of Immune Profiling for Differential Diagnosis between Crohn's Disease, Intestinal Tuberculosis, and Behcet's Disease.免疫谱分析在克罗恩病、肠结核和白塞病鉴别诊断中的临床应用价值
Diagnostics (Basel). 2023 Sep 11;13(18):2904. doi: 10.3390/diagnostics13182904.
5
ANO10 is a potential prognostic biomarker and correlates with immune infiltration in breast cancer.ANO10是一种潜在的预后生物标志物,与乳腺癌中的免疫浸润相关。
Am J Cancer Res. 2023 May 15;13(5):1845-1862. eCollection 2023.
6
A new prediction model of hepatocellular carcinoma based on N7-methylguanosine modification.基于 N7-甲基鸟苷修饰的肝细胞癌新预测模型。
BMC Gastroenterol. 2023 Apr 20;23(1):131. doi: 10.1186/s12876-023-02757-9.
7
Multiplexed molecular imaging with surface enhanced resonance Raman scattering nanoprobes reveals immunotherapy response in mice multichannel image segmentation.利用表面增强共振拉曼散射纳米探针进行多重分子成像可揭示小鼠免疫治疗反应的多通道图像分割。
Nanoscale Horiz. 2022 Nov 21;7(12):1540-1552. doi: 10.1039/d2nh00331g.
8
Influence of Androgen Deprivation Therapy on the PD-L1 Expression and Immune Activity in Prostate Cancer Tissue.雄激素剥夺疗法对前列腺癌组织中PD-L1表达及免疫活性的影响
Front Mol Biosci. 2022 Jun 28;9:878353. doi: 10.3389/fmolb.2022.878353. eCollection 2022.
9
Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer.构建一种新型免疫相关mRNA特征以预测人类结直肠癌的预后和免疫特征
Front Genet. 2022 Mar 23;13:851373. doi: 10.3389/fgene.2022.851373. eCollection 2022.
10
A nomogram-based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancer.基于列线图的免疫图谱可预测II期和III期人类结直肠癌的临床结局。
Mol Clin Oncol. 2021 Dec;15(6):257. doi: 10.3892/mco.2021.2419. Epub 2021 Oct 14.